Shares of Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) were up 12.9% on Friday . The stock traded as high as $1.04 and last traded at $1.04. Approximately 200 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 5,220 shares. The stock had previously closed at $0.92.
Ascletis Pharma Stock Up 12.9 %
The firm has a 50 day simple moving average of $0.47 and a two-hundred day simple moving average of $0.28.
Ascletis Pharma Company Profile
Ascletis Pharma Inc, a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis.
Further Reading
- Five stocks we like better than Ascletis Pharma
- What is a support level?
- How to Build the Ultimate Everything ETF Portfolio
- What Are Dividend Contenders? Investing in Dividend Contenders
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
